Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Loeffler endocarditis: what have we learned?

Juan Benezet-Mazuecos1, Adolfo de la Fuente, Pedro Marcos-Alberca

  • 1Department of Cardiology, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain. jbenezet@yahoo.es

American Journal of Hematology
|June 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preliminary validation of an echocardiographic formula for estimating left ventricular outflow tract area in severe aortic stenosis.

Revista espanola de cardiologia (English ed.)·2026
Same author

Impact of Supranormal LVEF After TAVI: Behavior, Mortality, and Cardiac Structure.

Journal of clinical medicine·2026
Same author

Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA.

European journal of heart failure·2026
Same author

The role of targeted therapies in blastic plasmacytoid dendritic cell neoplasm.

Expert opinion on biological therapy·2025
Same author

Giant Left Ventricular Aneurysmal Dilatation With Coexisting Pseudoaneurysm After Anterior STEMI: Multimodality Imaging-Guided Repair.

JACC. Case reports·2025
Same author

Ladder diagrams and cardiac arrhythmias.

Indian pacing and electrophysiology journal·2025
Same journal

Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" Trial.

American journal of hematology·2026
Same journal

Relapse Thresholds (12/24 Mo) Define Survival Disparity in Pediatric B-ALL.

American journal of hematology·2026
Same journal

Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II Trial.

American journal of hematology·2026
Same journal

Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation.

American journal of hematology·2026
Same journal

Safety and Efficacy of Plerixafor in Poor Mobilizers With Lymphoma: A Multicenter, Prospective, Single-Arm Study.

American journal of hematology·2026
Same journal

Dordaviprone Maintenance After Allogeneic HCT for High-Risk Acute Myeloid Leukemia and Myelodysplastic Neoplasm.

American journal of hematology·2026
See all related articles

Loeffler endocarditis, a rare eosinophilic heart disease, involves endocardial thickening and cardiac complications. Its exact causes remain unclear, but it

Area of Science:

  • Cardiology
  • Hematology
  • Pathology

Background:

  • Loeffler endocarditis, also known as eosinophilic endomyocardial disease, is a rare condition.
  • It is considered a subcategory of Hypereosinophilic syndrome, primarily affecting the heart.
  • Characterized by eosinophil-induced damage leading to endocardial thickening and apical obliteration.

Discussion:

  • The precise pathophysiological mechanisms underlying Loeffler endocarditis are not fully understood.
  • Various theories attempt to explain the disease's development and progression.
  • Management focuses on addressing the cardiovascular complications arising from endocardial damage.

Key Insights:

  • Eosinophilic endomyocardial disease presents with significant cardiac involvement.

Related Experiment Videos

  • The role of eosinophils in myocardial damage is a central hypothesis.
  • Unresolved questions persist regarding the disease's evolution and triggers.

    • Outlook:

    • Further research is needed to elucidate the exact mechanisms of Loeffler endocarditis.
    • Improved understanding may aid in earlier diagnosis and recognition globally.
    • Focus on managing cardiovascular sequelae is crucial for patient outcomes.